RMDN3 and amyotrophic lateral sclerosis: It has been implicated in neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) [58] and hereditary spastic paraplegia (HSP), where mutations in VAPB disrupt the regular interaction with PTPIP51, leading to cellular dysfunction and disease pathology.